Investigating biomarkers of Staphylococcus aureus bacteremia in patients - School of Pharmacy
Por um escritor misterioso
Descrição
The Centers for Disease Control identifies methicillin-resistant S. aureus (MRSA) as a serious health threat with greater than 100,000 invasive infections and 20,000 patient deaths annually in the United States. Despite recent advancements in available treatment options for methicillin-sensitive S.
Infection and the evaluation of biomarkers in obstetrics and gynecology patients with infectious disease: a retrospective observational study from clinical pharmacists' consultation experience, European Journal of Medical Research
Metabolites, Free Full-Text
Methicillin-resistant Staphylococcus aureus: novel treatment approach breakthroughs, Bulletin of the National Research Centre
Staphylococcus aureus Bacteremia in Adults
Frontiers Management of Staphylococcus aureus Bloodstream Infections
Platelet P2Y12 signalling pathway in the dysregulated immune response during sepsis - Amoafo - British Journal of Pharmacology - Wiley Online Library
Current Paradigms of Combination Therapy in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does it Work, Which Combination, and For Which Patients? - Abstract - Europe PMC
Methicillin-resistant Staphylococcus aureus: novel treatment approach breakthroughs, Bulletin of the National Research Centre
Frontiers Management of Staphylococcus aureus Bloodstream Infections
PDF) Select controversies in the management of methicillin-resistant Staphylococcus aureus bacteremia: answers and remaining questions from recent evidence
Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study - The Lancet Infectious Diseases
AFMR Southeastern Regional Meeting Supplement, 2023
Timing of follow-up blood cultures for community-onset bacteremia
de
por adulto (o preço varia de acordo com o tamanho do grupo)
